Northwest Biotherapeutics News and Activities

Northwest Biotherapeutics is a company listed under the stock ticker NWBO (US).

View the org chart displaying its 6 main executives

Most searched biographies at Northwest Biotherapeutics

• Linda Powers, Chief Executive Officer
• Cofer Black, Independent Director
• Pat Sarma, Director

Create your alert
to follow the executive moves at Northwest Biotherapeutics.

Northwest Biotherapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Northwest Biotherapeutics

• Press Releases - Northwest Biotherapeutics
• Press Releases - Northwest Biotherapeutics
• Press Releases - Northwest Biotherapeutics
• Press Releases - Northwest Biotherapeutics
• Press Releases - Northwest Biotherapeutics
• Northwest Biotherapeutics Press Releases - Northwest Biotherapeutics
• Northwest Biotherapeutics Press Releases - Northwest Biotherapeutics
• Northwest Biotherapeutics Press Releases - Northwest Biotherapeutics
• Northwest Biotherapeutics Press Releases - Northwest Biotherapeutics
• Northwest Biotherapeutics Press Releases - Northwest Biotherapeutics
• View more press releases Close

Social media about Northwest Biotherapeutics

• Northwest Biotherapeutics on Wikipedia, Google News & Yahoo Finance
• Northwest Biotherapeutics on LinkedIn, X (Twitter) & YouTube